Preemptive Action: Reducing the Risk of Breast Cancer

Publication
Article
Pharmacy TimesJune 2012 Women's Health
Volume 78
Issue 6

This continuing education activity addresses the factors that increase and decrease a woman's risk for breast cancer, and includes information for pharmacists to help provide evidence-based counseling on preventative measures.

Pharmacy Times Office of Continuing Professional Education

Preemptive Action: Reducing the Risk of Breast Cancer

Elena Beyzarov, PharmD

Scientific Director Pharmacy Times Office of Continuing Professional Education

Elena Beyzarov, PharmD, has no relevant affiliations or financial relationships with commercial interests to disclose related to this activity

Pharmacy Times Office of Continuing Professional Education Planning Staff

Judy V. Lum, MPA, and Ann C. Lichti, CCMEP have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.

Pharmacy Times Editorial

Bea Riemschneider, Jennifer Barrio, and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the current incidence and prevalence of breast cancer among American women.
  • Examine factors associated with increased risk of breast cancer, including lifestyle, genetic factors, and hormone replacement therapy.
  • Examine factors associated with decreased risk of breast cancer, focusing on chemoprevention strategies.
  • Discuss implications for pharmacists in regard to addressing common patient questions on breast cancer risks and providing evidence-based information on chemoprevention and use of dietary supplements.

Target Audience: Pharmacists

Type of Activity: Knowledge

Release date: June 10, 2012

Expiration date: June 10, 2014

Estimated time to complete activity: 2 hours

Fee: This lesson is free online at www.PharmacyTimes.com. There is a nominal fee of $10.00 for mailed/faxed evaluation and exam forms.

Click here to view this activity

Related Videos
A panel of 4 experts on breast cancer
A panel of 4 experts on breast cancer
cancer pain management | Image Credits: © Burlingham - stock.adobe.com
A panel of 4 experts
A panel of 4 experts
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign | stock.adobe.com
A panel of 4 experts
© 2024 MJH Life Sciences

All rights reserved.